JAYEMPI 10 mg/ml, oral suspension bottle, 200 ml
Active ingredients: Azathioprine
Commercialized according to BDPMDispensing in France: Prescription only
Oral suspensionbottle, 200 mlorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- JAYEMPI 10 mg/mL, suspension buvable
- Pharmaceutical form
- suspension buvable
- Route of administration
- orale
- Presentation description
- 1 flacon en verre avec fermeture de sécurité enfant polyéthylène haute densité (PEHD) de 200 mL + 2 seringues doseuses + 1 adaptateur de flacon
- Marketing authorisation holder
- LIPOMED (ALLEMAGNE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 1 Oct 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67197964CIP73031170CIP133400930311707Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| AZATHIOPRINEsuspension | 10 mg · 1 mL de suspension | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.